About 8 results found for searched term "JAK-IN-14" (0.169 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M41707 | JAK3-IN-14 | JAK |
| JAK3-IN-14 is a potent JAK3 inhibitor, with IC50 values of 38 and 600 nM for JAK3 and JAK2, respectively. | ||
| M49597 | JAK-IN-14 | JAK |
| JAK-IN-14 is a potent and selective JAK1 inhibitor, with an IC50 of <5 μM. | ||
| M9627 | JAK3-IN-6 (Compound 2) | JAK |
| JAK3-IN-2 | ||
| JAK3-IN-6 (Compound 2) CAS#: 1443235-95-7 is a potent and highly selective JAK3 inhibitor, with an IC50 of 0.15 nM. | ||
| M49504 | JAK-2/3-IN-3 | Apoptosis |
| JAK-2-/3-IN-3 is a potent JAK2/3 inhibitor with IC50s of 13.00 and 14.86 nM for JAK2 and JAK3, respectively. | ||
| M49565 | Ilunocitinib | JAK |
| Ilunocitinib is a JAK inhibitor (extracted from patent WO2009114512A1). | ||
| M49566 | Itacnosertib | JAK |
| Itacnosertib (TP-0184) is both inhibitor to JAK2, ACVR1 (ALK2) and ALK5 as described in WO2014151871. | ||
| M49602 | JAK-IN-20 | JAK |
| JAK-IN-20 is a potent, pan and orally active JAK inhibitor with an IC50s of 7 nM, 5 nM, 14 nM for JAK1, JAK2, JAK3, respectively. | ||
| M49776 | SJ10542 | PROTAC |
| SJ10542 is a potent and selective JAK2/3 directing phenyl glutarimide (PG)-PROTAC with DC50s of 14, 11, and 24 nM for JAK2, JAK3, and JAK2-fusion ALL, respectively. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
